Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential TherapeuticsM. Manning, Gilles Guillon, Aleksandra Misicka et al.|Journal of Neuroendocrinology|2012Cited by 424
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents☆M. Manning, Gilles Guillon, S. Stoev et al.|Progress in brain research|2008Cited by 289
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.Bice Chini, Serge Jard, M N Balestre et al.|The EMBO Journal|1995Cited by 181
Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challengesBice Chini, M. Manning|Biochemical Society Transactions|2007Cited by 124
A radioiodinated linear vasopressin antagonist: A ligand with high affinity and specificity for V<sub>1a</sub> receptorsAnne Schmidt, W. H. Sawyer, S. Audigier et al.|FEBS Letters|1991Cited by 83